Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

EMMESSAR CHM vs GSK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    EMMESSAR CHM GSK PHARMA EMMESSAR CHM/
GSK PHARMA
 
P/E (TTM) x 25.0 59.7 42.0% View Chart
P/BV x 2.9 22.5 13.0% View Chart
Dividend Yield % 0.0 1.3 -  

Financials

 EMMESSAR CHM   GSK PHARMA
EQUITY SHARE DATA
    EMMESSAR CHM
Mar-24
GSK PHARMA
Mar-24
EMMESSAR CHM/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs482,650 1.8%   
Low Rs211,228 1.7%   
Sales per share (Unadj.) Rs1.1203.9 0.5%  
Earnings per share (Unadj.) Rs1.534.8 4.3%  
Cash flow per share (Unadj.) Rs1.738.9 4.4%  
Dividends per share (Unadj.) Rs032.00 0.0%  
Avg Dividend yield %01.7 0.0%  
Book value per share (Unadj.) Rs14.8105.5 14.0%  
Shares outstanding (eoy) m5.00169.41 3.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x30.99.5 325.4%   
Avg P/E ratio x22.955.7 41.2%  
P/CF ratio (eoy) x20.349.8 40.7%  
Price / Book Value ratio x2.318.4 12.6%  
Dividend payout %091.9 0.0%   
Avg Mkt Cap Rs m172328,474 0.1%   
No. of employees `000NANA-   
Total wages/salary Rs m106,244 0.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m634,537 0.0%  
Other income Rs m201,226 1.6%   
Total revenues Rs m2535,763 0.1%   
Gross profit Rs m-117,651 -0.1%  
Depreciation Rs m1697 0.1%   
Interest Rs m018 0.1%   
Profit before tax Rs m88,162 0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m12,262 0.0%   
Profit after tax Rs m85,900 0.1%  
Gross profit margin %-194.722.2 -878.9%  
Effective tax rate %7.727.7 28.0%   
Net profit margin %135.117.1 790.7%  
BALANCE SHEET DATA
Current assets Rs m6927,984 0.2%   
Current liabilities Rs m515,249 0.0%   
Net working cap to sales %1,140.136.9 3,092.0%  
Current ratio x12.91.8 705.0%  
Inventory Days Days9115 7.9%  
Debtors Days Days147235 62.5%  
Net fixed assets Rs m196,119 0.3%   
Share capital Rs m501,694 2.9%   
"Free" reserves Rs m2416,172 0.1%   
Net worth Rs m7417,866 0.4%   
Long term debt Rs m00-   
Total assets Rs m8834,103 0.3%  
Interest coverage x814.0454.7 179.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.11.0 6.2%   
Return on assets %8.617.4 49.3%  
Return on equity %10.133.0 30.7%  
Return on capital %11.045.8 24.0%  
Exports to sales %46.00-   
Imports to sales %022.9 0.0%   
Exports (fob) Rs m3NA-   
Imports (cif) Rs mNA7,912 0.0%   
Fx inflow Rs m31,342 0.2%   
Fx outflow Rs m07,912 0.0%   
Net fx Rs m3-6,570 -0.0%   
CASH FLOW
From Operations Rs m65,820 0.1%  
From Investments Rs m-687 -7.4%  
From Financial Activity Rs mNA-5,615 -0.0%  
Net Cashflow Rs m0292 0.0%  

Share Holding

Indian Promoters % 59.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.2 11.7 1.7%  
FIIs % 0.0 4.4 -  
ADR/GDR % 0.0 0.0 -  
Free float % 40.5 25.0 161.9%  
Shareholders   6,936 119,228 5.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare EMMESSAR CHM With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on EMMESSAR CHM vs GSK Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

EMMESSAR CHM vs GSK Pharma Share Price Performance

Period EMMESSAR CHM GSK Pharma
1-Day 0.81% -1.57%
1-Month 8.23% -8.09%
1-Year 73.32% 44.07%
3-Year CAGR 20.59% 10.56%
5-Year CAGR 34.12% 7.44%

* Compound Annual Growth Rate

Here are more details on the EMMESSAR CHM share price and the GSK Pharma share price.

Moving on to shareholding structures...

The promoters of EMMESSAR CHM hold a 59.5% stake in the company. In case of GSK Pharma the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of EMMESSAR CHM and the shareholding pattern of GSK Pharma.

Finally, a word on dividends...

In the most recent financial year, EMMESSAR CHM paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

GSK Pharma paid Rs 32.0, and its dividend payout ratio stood at 91.9%.

You may visit here to review the dividend history of EMMESSAR CHM, and the dividend history of GSK Pharma.



Today's Market

Sensex Today Zooms Over 1,200 Points | Nifty Above 24,300 | Adani Ports Climbs 4% Sensex Today Zooms Over 1,200 Points | Nifty Above 24,300 | Adani Ports Climbs 4%(10:30 am)

Asian stocks experienced a notable rally alongside US equity futures on Monday, marking a positive turn for the markets. The dollar retreated against other currencies as bond yields declined.